Global Ganja Report

With the legal cannabis market increasingly dominated by "Big Bud," more Canadians are turning to homegrown—both for reasons of economy and an ethic of self-sufficiency. And they are fighting in the courts and the public squares for their right to do so—challenging both the federal limit on plants per household and efforts by two provinces to ban homegrown outright. So far, they are winning. 

Cannabis is turning into a key issue testing the limits of First Nations sovereignty in Canada—right up there with the long-standing struggles over oil, mineral, timber and hydro-electric development. At least one First Nation is operating a cannabis outlet without provincial authorization, in a direct challenge to authorities. And if accommodations are not reached with provincial and federal regulators, more may be set to follow.

Cannabis industry leaders have announced certification standards to promote corporate responsibility. The move appears to be prompted by some embarrassing scandals in the young industry. Activists are meanwhile raising more far-reaching demands for drug war "reparations." 

Harborside, the San Francisco Bay Area's flagship cannabis dispensary chain, is going public on the Canadian stock exchange. Founder and chairman emeritus of the company, Steve DeAngelo, speaks with Cannabis Now about what this means for Harborside's future and the fast-evolving cannabis industry.

As New Zealand waits on a promised cannabis legalization referendum, a domestic industry is starting to blossom, with big capital inflows reported. But police cannabis seizures are actually up—and the government even shows sings of wavering on following through with its commitment to hold a binding referendum.

A showdown is shaping up in Vancouver, where the city's 420 event has always been held with no permit. This year it promises to be huge, with Cypress Hill headlining—and authorities pressing for cancellation. Organizers pledge the event will go ahead—with approval of the bureaucracy or not.

There is a growing consensus among hemp advocates that the 0.3% limit for THC content is arbitrary and is holding back the industry. And the man widely credited with arriving at this limit himself agrees.

The Contested Border
"It seems like it is pretty much pulled out of air. We ought to be looking to science to determine an appropriate threshold, determine the level at which cannabis is psychoactive and make that the standard."

This typical view is offered by attorney Patrick Goggin of Hoban Law Group, the international firm specializing in cannabis. Goggin is one of the industry's legal heavy-hitters, and has particular experience in the question of the contested border between hemp and marijuana.

Insurance companies in Canada are starting to cover medical marijuana, but high costs continue to be an impediment to access in the United States. Even in states that have legalized medicinal use of cannabis, the insurance industry will provide no coverage. Advocates are now starting to demand legislation to address this contradiction.